[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-EXEL":3,"homepage-market-summary":30,"stock-news-EXEL":171},{"ticker":4,"date":5,"profile":6,"dividend":9,"quote":15},"EXEL","2026-10-02",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9,"is_fund":14,"issuer":9,"category":9},"Exelixis Inc","Nasdaq",null,"BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)","Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.","1,077","Alameda, CA",false,{"close":16,"open":17,"high":18,"low":19,"prev_close":19,"change":20,"percent_change":21,"volume":22,"transactions":23,"vwap":24,"high_52w":25,"low_52w":26,"avg_volume_52w":27,"range_52w_percent":28,"record_count":29},58.39,58.11,58.97,57.94,0.45,0.78,1949268.23419,27035,58.4362,61.14,33.76,2638096.850749768,90,6654,{"status":31,"indices":32,"watchlist":76,"sectors":98,"benchmarks":153},"success",[33,41,48,55,62,69],{"symbol":34,"name":35,"price":36,"change":37,"pct_change":38,"is_up":39,"sparkline":40,"date":5},"SPX","S&P 500",7722.72,56.27,0.73,true,"0.0,5.0 2.3,8.0 4.6,10.4 6.9,13.4 9.3,9.1 11.6,11.5 13.9,13.8 16.2,16.0 18.5,10.3 20.8,9.5 23.2,2.0 25.5,2.0 27.8,5.9 30.1,6.0 32.4,3.4 34.7,7.3 37.1,8.2 39.4,9.4 41.7,8.5 44.0,4.8",{"symbol":42,"name":43,"price":44,"change":45,"pct_change":46,"is_up":39,"sparkline":47,"date":5},"NDX","NASDAQ 100",30807.93,306.37,1,"0.0,11.5 2.3,11.7 4.6,12.4 6.9,14.8 9.3,12.8 11.6,14.6 13.9,16.0 16.2,15.9 18.5,12.2 20.8,10.7 23.2,4.4 25.5,2.6 27.8,4.5 30.1,4.5 32.4,3.5 34.7,6.0 37.1,5.5 39.4,5.0 41.7,4.3 44.0,2.0",{"symbol":49,"name":50,"price":51,"change":52,"pct_change":53,"is_up":39,"sparkline":54,"date":5},"DJI","DOW JONES",51177,250,0.49,"0.0,2.0 2.3,5.5 4.6,7.8 6.9,9.5 9.3,6.7 11.6,7.5 13.9,9.4 16.2,12.9 18.5,11.1 20.8,11.7 23.2,9.6 25.5,10.7 27.8,12.6 30.1,13.5 32.4,10.8 34.7,12.8 37.1,13.5 39.4,16.0 41.7,15.9 44.0,14.5",{"symbol":56,"name":57,"price":58,"change":59,"pct_change":60,"is_up":39,"sparkline":61,"date":5},"COMP","NASDAQ Composite",27190.86,319.27,1.19,"0.0,10.2 2.3,11.1 4.6,13.0 6.9,14.9 9.3,12.1 11.6,13.7 13.9,16.0 16.2,16.0 18.5,11.1 20.8,10.0 23.2,3.4 25.5,2.0 27.8,5.4 30.1,5.4 32.4,3.9 34.7,6.7 37.1,6.9 39.4,6.2 41.7,6.1 44.0,2.6",{"symbol":63,"name":64,"price":65,"change":66,"pct_change":67,"is_up":39,"sparkline":68,"date":5},"RUT","RUSSELL 2000",2815.2,25,0.9,"0.0,2.0 2.3,3.0 4.6,6.1 6.9,8.4 9.3,7.5 11.6,8.8 13.9,10.4 16.2,11.3 18.5,10.2 20.8,11.2 23.2,10.1 25.5,8.8 27.8,12.9 30.1,13.1 32.4,12.8 34.7,14.4 37.1,15.1 39.4,16.0 41.7,15.1 44.0,13.2",{"symbol":70,"name":71,"price":72,"change":73,"pct_change":74,"is_up":14,"sparkline":75,"date":5},"VIX","CBOE VIX",15.31,-1.08,-6.59,"0.0,14.8 2.3,10.2 4.6,7.3 6.9,2.0 9.3,9.7 11.6,4.9 13.9,4.5 16.2,2.5 18.5,11.3 20.8,13.7 23.2,13.5 25.5,16.0 27.8,12.3 30.1,10.4 32.4,13.5 34.7,8.8 37.1,8.9 39.4,7.8 41.7,7.6 44.0,11.8",[77,84,91],{"symbol":78,"name":79,"price":80,"change":81,"pct_change":82,"is_up":39,"sparkline":83,"date":5},"NVDA","NVIDIA Corp",233.95,3.09,1.34,"0.0,16.0 7.3,15.3 14.7,9.6 22.0,12.1 29.3,10.3 36.7,6.6 44.0,2.0",{"symbol":85,"name":86,"price":87,"change":88,"pct_change":89,"is_up":39,"sparkline":90,"date":5},"AAPL","Apple Inc",333.69,3.37,1.02,"0.0,8.2 7.3,2.0 14.7,5.2 22.0,16.0 29.3,11.7 36.7,14.9 44.0,10.9",{"symbol":92,"name":93,"price":94,"change":95,"pct_change":96,"is_up":39,"sparkline":97,"date":5},"TSLA","Tesla Inc",370.59,16.48,4.65,"0.0,2.0 7.3,5.3 14.7,13.4 22.0,16.0 29.3,14.9 36.7,15.3 44.0,6.1",[99,104,109,114,119,124,129,133,138,143,148],{"name":100,"etf":101,"change":102,"price":103,"is_up":39},"Technology","XLK",1.01,199.81,{"name":105,"etf":106,"change":107,"price":108,"is_up":39},"Financials","XLF",0.06,53.49,{"name":110,"etf":111,"change":112,"price":113,"is_up":14},"Healthcare","XLV",-0.01,166.18,{"name":115,"etf":116,"change":117,"price":118,"is_up":39},"Consumer Cycl","XLY",1.13,110.04,{"name":120,"etf":121,"change":122,"price":123,"is_up":39},"Consumer Staples","XLP",0.25,80.53,{"name":125,"etf":126,"change":127,"price":128,"is_up":39},"Energy","XLE",0.4,62.95,{"name":130,"etf":131,"change":21,"price":132,"is_up":39},"Industrials","XLI",169.95,{"name":134,"etf":135,"change":136,"price":137,"is_up":39},"Materials","XLB",0.66,48.86,{"name":139,"etf":140,"change":141,"price":142,"is_up":39},"Real Estate","XLRE",0.32,40.81,{"name":144,"etf":145,"change":146,"price":147,"is_up":39},"Utilities","XLU",0.38,39.83,{"name":149,"etf":150,"change":151,"price":152,"is_up":39},"Comm Services","XLC",0.35,110.32,[154,159,163,167],{"ticker":155,"name":156,"price":157,"change":158,"is_up":39},"SPY","SPDR S&P 500 ETF",769.64,0.74,{"ticker":160,"name":161,"price":162,"change":89,"is_up":39},"QQQ","Invesco QQQ Trust",749.58,{"ticker":164,"name":165,"price":166,"change":53,"is_up":39},"DIA","SPDR Dow Jones ETF",511.1,{"ticker":168,"name":169,"price":170,"change":67,"is_up":39},"IWM","iShares Russell 2000",281.52,{"ticker":4,"count":172,"articles":173},9,[174,180,186,192,198,204,210,216,222],{"title":175,"link":176,"pubDate":177,"description":178,"source":179},"Exelixis, Inc. (EXEL) Stock Price, News, Quote & History - Yahoo! Finance Canada","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiUkFVX3lxTE1zc1pHQWJhRjdfX1pYaHFRY2pKZkx3SWV0dTA1VU5TdmpCMWpFUm1YT0JTS0MteGF6X1VhaldrS3VoTGc0dmh0TlYtZ1NidkE0V2c?oc=5","Sun, 04 Oct 2026 07:15:42 GMT","Exelixis, Inc. (EXEL) Stock Price, News, Quote & History Yahoo! Finance Canada","Yahoo! Finance Canada",{"title":181,"link":182,"pubDate":183,"description":184,"source":185},"Could Zanzalintinib's FDA Delay Affect Exelixis' Growth Plans? - TradingView","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMitwFBVV95cUxPZXMzeS02SkxCYTJjWnZ6SmJFUkRibDhfeTItekEzSXVVM0tIMXRCZHhwbzExZGtybjdKVlpBTjYtdHVtYU05TmozVDBQc2FvWFNqRjlyRk05SEtjazdCeEt2QS1pWFFwMjlBM2FhMlltaVAxcm8tYUM5YV9SNFlzWTN2bzlUWmZTdGNPa2UteENqTGNFdExTVWwta05kV1BsQXpqbkhMOXJfdFMyZllMWjk4WkFITms?oc=5","Thu, 24 Sep 2026 15:48:00 GMT","Could Zanzalintinib's FDA Delay Affect Exelixis' Growth Plans? TradingView","TradingView",{"title":187,"link":188,"pubDate":189,"description":190,"source":191},"How Investors Are Reacting To Exelixis (EXEL) FDA Review Extension - Simply Wall Street","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\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?oc=5","Wed, 23 Sep 2026 18:37:36 GMT","How Investors Are Reacting To Exelixis (EXEL) FDA Review Extension Simply Wall Street","Simply Wall Street",{"title":193,"link":194,"pubDate":195,"description":196,"source":197},"(EXEL) Volatility Zones as Tactical Triggers - Stock Traders Daily","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMivwFBVV95cUxNcW9HWlEzSGx3bnJ2cEE1S2ttMUJJVG5nVU5EUXdaa3VVZ0hBZ3ctVXlfRHo4RDNRcHFRb19rZng5bzZTWHZvU2xHRGZvbVVEMi12MVhreHFxcXZiRmNBQVV0S1dLRFdXUmx0UkpiQXl2djZCdXkwczI1dUtWd3Z3RXJYalJLa0dYUVV1VlVVUGNpYUMtSk5sbUZvemRpeDNaeVItMUp6b3d5S3lCQWVPRjRzMUJ3azhCQW94STlOOA?oc=5","Thu, 01 Oct 2026 11:14:02 GMT","(EXEL) Volatility Zones as Tactical Triggers Stock Traders Daily","Stock Traders Daily",{"title":199,"link":200,"pubDate":201,"description":202,"source":203},"Exelixis (EXEL) Gets FDA Review Extension For Zanzalintinib განაცხად tometastatic Colorectal Cancer - Yahoo Finance","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMilAFBVV95cUxOZVlhbEF3eklnUmdFR2syS3F5V0l0Qzlza19XYUxoWFpLUVU2TzY2R0FXem5xekpYckF2TU0xT1pWWXdBbWNnaUJWb0tjbzVZVklZYXpoejZyZlp0T3dTNmgyZ0Z6OEJucWFkMWpDTC1UYzNBdVBVeVFKLVNtUEtySm54ZEVqWmdJeEtsSTlzc1hSamlY?oc=5","Mon, 21 Sep 2026 07:00:00 GMT","Exelixis (EXEL) Gets FDA Review Extension For Zanzalintinib განაცხად tometastatic Colorectal Cancer Yahoo Finance","Yahoo Finance",{"title":205,"link":206,"pubDate":207,"description":208,"source":209},"Exelixis Shares Rising on CABOMETYX Revenue - FXEmpire","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMimgFBVV95cUxNUGVGNFFpRmpBaFFVZFVEVk1jVl9FdUF2cjhDVHdWSWJ0V2ZkRGN2a3J5SVgxeEFIWDNiYlgwQXhaUmpORjdWNlVvclhxeXQxNXB2V1dGN2dzR3Z6aTlySFBDdmZxVVlUS0hYd3JySmpyeGNQS09VNjcySnVyNnRYaEFlZEE2OWRwS2JsbTVXRG15M0s0TEZDMkZ3?oc=5","Thu, 01 Oct 2026 02:43:00 GMT","Exelixis Shares Rising on CABOMETYX Revenue FXEmpire","FXEmpire",{"title":211,"link":212,"pubDate":213,"description":214,"source":215},"How Is Incyte’s Stock Performance Compared to Other Biotech Stocks? - inkl","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMilgFBVV95cUxNdWFMTW1tcVkteGQtdzFMTmhKVkNxdFUyUmJlXzVDVGZzQjJkSk1iOFRpb3NDVkUwNzdJS2RNQmNCRVdGY1JaVUVCOGlFWW01cXFoSjNOZ1FfZGNrdVhBaHVjMV9EejRkdHNVZnVFM2Eyd080Q09ta2ZTUjhIcUtIWTdROWlaTW9LYVdnODlHLXFTRHBVUmc?oc=5","Tue, 22 Sep 2026 07:00:00 GMT","How Is Incyte’s Stock Performance Compared to Other Biotech Stocks? inkl","inkl",{"title":217,"link":218,"pubDate":219,"description":220,"source":221},"EXEL Oct 2026 40.000 call (EXEL261016C00040000) stock historical prices and data - Yahoo Finance Singapore","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMicEFVX3lxTE1LdzlTckVqekxKelNPV3VOTG5lQnFJXzZ3QkxPRXByMTVBYVFsQnRKSkhnUFA2VmVDd0FqV3hZdUNVYWw5LXNadlEwSnFyU3lvdlF5MUh5d1U5Y3VGSWhwQ3dZR2lxbWNWM0lfMjhuZWE?oc=5","Wed, 30 Sep 2026 18:13:51 GMT","EXEL Oct 2026 40.000 call (EXEL261016C00040000) stock historical prices and data Yahoo Finance Singapore","Yahoo Finance Singapore",{"title":223,"link":224,"pubDate":225,"description":226,"source":227},"EXEL Industries Updates Share Capital and Voting Rights as of September 30, 2026 - TipRanks","https:\u002F\u002Fnews.google.com\u002Frss\u002Farticles\u002FCBMiywFBVV95cUxQaEJjLUlPX0dmblh3YUo1VjRfX0lYOFlUc0p3RlJBQ3RheTFBdUxhWEpoTWliU0VETkU4Z1ZxcGRqekRna0V1ZjNPWkFCaTN4ZDBxZW85UjFfWFlDck1PR3pOUzNRaEhuZUMwRDNDblJZMnRrcFRDQ1QwSVdCdVRpQXU5Z1dwa0NCRE5rZDVYMWd6N3FaeGZGdVVhYlh5SmxWVmVZNFVQSmpEd1dYbW5kRXVaVDVTTGE2RC1mM0pjWFloVHhUaVZmeFc3RQ?oc=5","Fri, 02 Oct 2026 17:11:21 GMT","EXEL Industries Updates Share Capital and Voting Rights as of September 30, 2026 TipRanks","TipRanks"]